Bazan, V <br/><br/>
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Dec 2002 
 - 650-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0171-5216 
<br/><br/><label>Standard No.: </label>10.1007/s00432-002-0394-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--genetics<br/>Adenocarcinoma, Mucinous--genetics<br/>Biomarkers, Tumor--analysis<br/>Cell Division<br/>Colon--pathology<br/>Colorectal Neoplasms--genetics<br/>DNA, Neoplasm--genetics<br/>Disease-Free Survival<br/>Humans<br/>Immunohistochemistry<br/>Lymph Nodes--pathology<br/>Monomeric GTP-Binding Proteins--genetics<br/>NM23 Nucleoside Diphosphate Kinases<br/>Neoplasm Staging<br/>Nucleoside-Diphosphate Kinase<br/>Ploidies<br/>Predictive Value of Tests<br/>S Phase<br/>Survival Analysis<br/>Time Factors<br/>Transcription Factors--genetics<br/>Treatment Outcome<br/>Tumor Suppressor Protein p53--genetics